Ultragenyx制藥
RARE----
全部股東
股東類型
- 機構投資者84.19%
- 對沖基金12.68%
- 個人與內幕人士3.13%
- 私人企業<0.01%
- 國有企業0.00%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
BlackRock, Inc. | 10.84% | 1,065.43 萬 | 3.40% | +335.47 萬 | 30/06/2026 |
RTW Investments, LP | 7.93% | 779.69 萬 | 4.21% | +414.81 萬 | 30/06/2026 |
Vanguard Portfolio Management, LLC | 6.91% | 679.01 萬 | 1.42% | +140.41 萬 | 30/06/2026 |
AQR Capital Management, LLC | 6.65% | 653.40 萬 | 2.00% | +197.27 萬 | 30/06/2026 |
State Street Investment Management | 6.27% | 615.88 萬 | 1.15% | +113.73 萬 | 30/06/2026 |
Vanguard Capital Management, LLC | 5.05% | 496.79 萬 | 0.16% | +16.99 萬 | 30/06/2026 |
Two Sigma Investments, LP | 3.68% | 362.12 萬 | 1.44% | +141.54 萬 | 30/06/2026 |
Sands Capital Management, LLC | 3.21% | 315.84 萬 | 0.06% | -5.62 萬 | 30/06/2026 |
Jacobs Levy Equity Management Inc | 2.99% | 293.97 萬 | 1.53% | +150.86 萬 | 30/06/2026 |
Frontier Capital Management Co LLC | 2.90% | 284.79 萬 | 0.66% | +65.68 萬 | 30/06/2026 |
Emil KakkisFounder, President, CEO & Director | 2.80% | 275.48 萬 | 0.62% | +61.36 萬 | 16/04/2026 |
Geode Capital Management, LLC | 2.62% | 257.88 萬 | 0.74% | +72.94 萬 | 30/06/2026 |
Bellevue Asset Management AG | 2.02% | 198.28 萬 | 0.41% | -39.72 萬 | 30/06/2026 |
D. E. Shaw & Co., L.P. | 1.76% | 173.02 萬 | 0.48% | +46.92 萬 | 30/06/2026 |
Sofinnova Investments, Inc. | 1.75% | 171.75 萬 | 1.46% | -142.84 萬 | 30/06/2026 |
Adage Capital Management, L.P. | 1.61% | 158.00 萬 | 1.12% | +110.00 萬 | 30/06/2026 |
GW&K Investment Management, LLC | 1.51% | 148.12 萬 | 0.14% | -13.42 萬 | 30/06/2026 |
MPM BioImpact LLC | 1.44% | 141.82 萬 | 1.44% | +141.82 萬 | 30/06/2026 |
T. Rowe Price Group, Inc. | 1.38% | 135.65 萬 | 0.56% | +55.24 萬 | 30/06/2026 |
Wellington Management Group LLP | 1.27% | 125.05 萬 | 1.42% | -139.03 萬 | 30/06/2026 |